Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nam

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Annals of the Rheumatic Diseases|May 8, 2010
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RAJ L Nam, K L Winthrop, R F van Vollenhoven, et al.
JAMA Network Open|June 8, 2019
Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without ArthritisKulveer Mankia, Zijian Cheng, Thuy Do, et al.
Rheumatology (Oxford, England)|February 17, 2024
The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trialsKaoru Takase-Minegishi, Stefan Böhringer, Jackie L Nam, et al.
Annals of the Rheumatic Diseases|April 15, 2014
Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort studyC Rakieh, J L Nam, L Hunt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
Anti-cancer effect of adenovirus p53 on human cervical cancer cell growth in vitro and in vivoW S Ahn, S M Bae, J M Lee, et al.
Annals of the Rheumatic Diseases|March 12, 2017
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritisJackie L Nam, Kaoru Takase-Minegishi, Sofia Ramiro, et al.
Annals of Internal Medicine|July 31, 2023
Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk StratificationLaurence Duquenne, Elizabeth M Hensor, Michelle Wilson, et al.
Conflict and Health|December 7, 2025
Setting research priorities for sexual and reproductive health in humanitarian settings: a global, stakeholder-informed agendaSara L Nam, Arantza Abril, Gillian McKay, et al.
Annals of the Rheumatic Diseases|March 17, 2017
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritisSofia Ramiro, Alexandre Sepriano, Katerina Chatzidionysiou, et al.
Annals of the Rheumatic Diseases|March 13, 2014
A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trialJ L Nam, E Villeneuve, E M A Hensor, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Annals of the Rheumatic Diseases|May 8, 2010
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RAJ L Nam, K L Winthrop, R F van Vollenhoven, et al.
JAMA Network Open|June 8, 2019
Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without ArthritisKulveer Mankia, Zijian Cheng, Thuy Do, et al.
Rheumatology (Oxford, England)|February 17, 2024
The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trialsKaoru Takase-Minegishi, Stefan Böhringer, Jackie L Nam, et al.
Annals of the Rheumatic Diseases|April 15, 2014
Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort studyC Rakieh, J L Nam, L Hunt, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
Anti-cancer effect of adenovirus p53 on human cervical cancer cell growth in vitro and in vivoW S Ahn, S M Bae, J M Lee, et al.
Annals of the Rheumatic Diseases|March 12, 2017
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritisJackie L Nam, Kaoru Takase-Minegishi, Sofia Ramiro, et al.
Annals of Internal Medicine|July 31, 2023
Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk StratificationLaurence Duquenne, Elizabeth M Hensor, Michelle Wilson, et al.
Conflict and Health|December 7, 2025
Setting research priorities for sexual and reproductive health in humanitarian settings: a global, stakeholder-informed agendaSara L Nam, Arantza Abril, Gillian McKay, et al.
Annals of the Rheumatic Diseases|March 17, 2017
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritisSofia Ramiro, Alexandre Sepriano, Katerina Chatzidionysiou, et al.
Annals of the Rheumatic Diseases|March 13, 2014
A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trialJ L Nam, E Villeneuve, E M A Hensor, et al.
Pageof 7